Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I Studies of Chemopreventive Agents, Workstatement 37-261995037
Fox Chase Cancer Center, Philadelphia, PA, United States
Search grants from Fox Chase Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mitochondrial metabolism and bone formation
Altered mechanical loads and skeletal muscle phenotype
Diet Impacts Nutrient Transfer to Subsequent Generations
Complex Survey Analytical Software Development
Moisture Sensing System
Recently added grants:
Bio-tribo-corrosion resistant 3D Printed Composites for Load-bearing Implants
Brain-selective estrogen therapy for menopausal hot flushes in an advanced translational animal model
Expanding the known coding genome: identifying biological function for novel tORFs
Technology Facilitated Behavioral Intervention for Depression among Diverse Patients in Ambulatory Oncology
Corticospinal neuron dysfunction and degeneration in ALS: testing the role of corticomotor connectivity in motor neuron disease
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095037-004
Application #
6688606
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Publications
Bellacosa, Alfonso; Godwin, Andrew K; Peri, Suraj et al.
(2010)
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations.
Cancer Prev Res (Phila) 3:48-61
Comments
Be the first to comment on this grant